Related Experiment Videos

Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice

G A He1, H M Hou, X J Liu

  • 1National Pharmaceutical Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China. ghe@mail.mdanderson.org

Acta Pharmacologica Sinica
|December 19, 2001
PubMed
Abstract

Insights

Sustained-release naltrexone microspheres show varying effects on morphine analgesia. Poly(lactic-co-glycolic acid) composition and drug loading influence naltrexone release and its antagonism duration.

Area of Science:

  • Pharmacology
  • Drug Delivery Systems
  • Biomaterials

Background:

  • Naltrexone is an opioid antagonist.
  • Sustained-release formulations aim to improve therapeutic outcomes.
  • Understanding drug release kinetics is crucial for efficacy.

Purpose of the Study:

  • To evaluate in vitro naltrexone release from biodegradable microspheres.
  • To assess the in vivo effect of these microspheres on morphine analgesia.
  • To correlate in vitro release with in vivo antagonist effects.

Main Methods:

  • High-performance liquid chromatography (HPLC) for drug release quantification.
  • Mouse hot-plate test to measure antianalgesic effects.
  • Utilized four distinct biodegradable microsphere formulations.

Main Results:

  • Poly(lactic-co-glycolic acid) (PLGA) composition significantly impacted naltrexone release and antagonism.
  • PLGA 50:50 formulations showed rapid release (>80%) and lost antagonism by 8 days.
  • PLGA 75:25 formulations with higher drug loading demonstrated prolonged antagonism (30-40 days).

Conclusions:

  • In vitro naltrexone release kinetics from microspheres directly correlate with in vivo antagonism of morphine analgesia.
  • Microsphere formulation, specifically PLGA ratio and drug loading, dictates the duration of naltrexone's antagonist effect.

Related Concept Videos